Canada
· Delayed Price · Currency is CAD DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of CAD 30.56 million. The enterprise value is 31.02 million.
| Market Cap | 30.56M |
| Enterprise Value | 31.02M |
Important Dates
The next estimated earnings date is Friday, June 6, 2025.
| Earnings Date | Jun 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DIAGNOS has 101.86 million shares outstanding. The number of shares has increased by 14.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 101.86M |
| Shares Change (YoY) | +14.91% |
| Shares Change (QoQ) | +13.81% |
| Owned by Insiders (%) | 5.47% |
| Owned by Institutions (%) | n/a |
| Float | 96.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 193.80 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.26 |
| EV / Sales | 243.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.59 |
Financial Position
The company has a current ratio of 0.95
| Current Ratio | 0.95 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.12 |
| Interest Coverage | -5.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.03% |
| Return on Invested Capital (ROIC) | -127.84% |
| Return on Capital Employed (ROCE) | -17,034.16% |
| Revenue Per Employee | 5,791 |
| Profits Per Employee | -170,818 |
| Employee Count | 22 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.15% in the last 52 weeks. The beta is -0.59, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.59 |
| 52-Week Price Change | +19.15% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.32 |
| Relative Strength Index (RSI) | 37.14 |
| Average Volume (20 Days) | 88,453 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of CAD 127,403 and -3.76 million in losses. Loss per share was -0.05.
| Revenue | 127,403 |
| Gross Profit | -871,403 |
| Operating Income | -3.20M |
| Pretax Income | -3.76M |
| Net Income | -3.76M |
| EBITDA | -3.17M |
| EBIT | -3.20M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 2.82 million in cash and 3.29 million in debt, giving a net cash position of -465,736 or -0.00 per share.
| Cash & Cash Equivalents | 2.82M |
| Total Debt | 3.29M |
| Net Cash | -465,736 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -477,206 |
| Book Value Per Share | -0.01 |
| Working Capital | -152,535 |
Cash Flow
In the last 12 months, operating cash flow was -2.92 million and capital expenditures -13,208, giving a free cash flow of -2.93 million.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | -13,208 |
| Free Cash Flow | -2.93M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,509.07% |
| Pretax Margin | -2,949.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.91% |
| Shareholder Yield | -14.91% |
| Earnings Yield | -12.30% |
| FCF Yield | -9.58% |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -22.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.52 |
| Piotroski F-Score | n/a |